Back

Functional alteration of innate T cells in critically ill Covid-19 patients

Jouan, Y.; Guillon, A.; Gonzalez, L.; Perez, Y.; Ehrmann, S.; Ferreira, M.; Daix, T.; Jeannet, R.; Francois, B.; Dequin, P.-F.; Si-Tahar, M.; Baranek, T.; Paget, C.

2020-05-06 intensive care and critical care medicine
10.1101/2020.05.03.20089300
Show abstract

Covid-19 can induce lung infection ranging from mild pneumonia to life-threatening acute respiratory distress syndrome (ARDS). Dysregulated host immune response in the lung is a key feature in ARDS pathophysiology. However, cellular actors in Covid-19-driven ARDS are poorly understood. Here, we dynamically analyzed the biology of innate T cells, a heterogeneous class (MAIT, {gamma}{delta}T and iNKT cells) of T lymphocytes, presenting potent anti-infective and regulatory functions. Patients presented a compartmentalized lung inflammation paralleled with a limited systemic inflammation. Circulating innate T cells of critically ill Covid-19 patients presented a profound and persistent phenotypic and functional alteration. Highly activated innate T cells were detected in airways of patients suggesting a recruitment to the inflamed site and a potential contribution in the regulation of the local inflammation. Finally, the expression of the CD69 activation marker on blood iNKT and MAIT cells at inclusion was predictive of disease severity. Thus, patients present an altered innate T cell biology that may account for the dysregulated immune response observed in Covid-19-related acute respiratory distress syndrome.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Frontiers in Immunology
based on 140 papers
Top 0.3%
13.0%
2
iScience
based on 74 papers
Top 0.1%
8.1%
3
Nature Communications
based on 483 papers
Top 11%
7.4%
4
Journal of Experimental Medicine
based on 10 papers
Top 0.1%
5.7%
5
PLOS ONE
based on 1737 papers
Top 67%
5.2%
6
Clinical & Translational Immunology
based on 14 papers
Top 0.1%
5.2%
7
Critical Care
based on 14 papers
Top 0.4%
4.4%
8
Frontiers in Medicine
based on 99 papers
Top 4%
4.4%
50% of probability mass above
9
Nature
based on 58 papers
Top 1%
4.4%
10
European Respiratory Journal
based on 44 papers
Top 1%
4.4%
11
Scientific Reports
based on 701 papers
Top 56%
2.8%
12
JCI Insight
based on 63 papers
Top 2%
2.8%
13
eLife
based on 262 papers
Top 12%
2.4%
14
Cells
based on 14 papers
Top 0.4%
2.4%
15
Nature Immunology
based on 14 papers
Top 0.8%
1.5%
16
Science Translational Medicine
based on 40 papers
Top 3%
1.3%
17
American Journal of Respiratory and Critical Care Medicine
based on 23 papers
Top 1%
1.3%
18
The Journal of Infectious Diseases
based on 137 papers
Top 8%
1.3%
19
Aging
based on 18 papers
Top 3%
1.2%
20
Genomics, Proteomics & Bioinformatics
based on 10 papers
Top 2%
0.8%
21
Cell
based on 28 papers
Top 3%
0.7%
22
EBioMedicine
based on 21 papers
Top 3%
0.7%
23
eBioMedicine
based on 82 papers
Top 9%
0.7%
24
Science Immunology
based on 15 papers
Top 2%
0.7%
25
Journal of Clinical Investigation
based on 50 papers
Top 5%
0.7%
26
ERJ Open Research
based on 36 papers
Top 4%
0.7%
27
Cell Reports Medicine
based on 49 papers
Top 6%
0.7%
28
The Lancet Respiratory Medicine
based on 16 papers
Top 2%
0.7%